Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Research Infrastructure Development (MRID) is a Japanese healthcare technology and service company dedicated to modernizing the clinical trial landscape. Established as a strategic initiative by M3, Inc. and Sony Corporation, the company provides infrastructure solutions that streamline the recruitment of patients and the management of clinical research sites. MRID leverages M3's vast network of physicians to identify eligible trial participants more efficiently than traditional methods. Its service portfolio includes site management organization (SMO) support, clinical research coordinator (CRC) staffing, and the development of IT platforms for trial data management. By integrating digital tools into the research process, MRID aims to accelerate drug development timelines and reduce costs for pharmaceutical sponsors. The company plays a vital role in the M3 Group's broader mission to improve medical efficiency through technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Research Infrastructure Development.